Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0M4BB
|
|||
| Former ID |
DIB013594
|
|||
| Drug Name |
Chi Lob 7/4
|
|||
| Synonyms |
Anti-CD40 MAb (chimeric, cancer), Cancer Research UK
Click to Show/Hide
|
|||
| Indication | B-cell lymphoma [ICD-11: 2A86; ICD-10: C85.1; ICD-9: 202.8] | Phase 1 | [1] | |
| Company |
Cancer Research UK
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01561911) A Phase I Study of the Chimeric Anti-CD40 Monoclonal Antibody ChiLob 7/4 to Treat Advanced Malignancies Refractory to Conventional Anti-cancer Treatment. U.S. National Institutes of Health. | |||
| REF 2 | Agonistic CD40 antibodies and cancer therapy | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.